Skip to content

The Effect of Homoeopathic Medicines Made from Mineral Sources in Children with Speech and Language Delay

A PROSPECTIVE OPEN LABEL SINGLE-ARM INTERVENTIONAL STUDY ON THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES FROM MINERAL SOURCES IN THE MANAGEMENT OF SPEECH AND LANGUAGE DELAY IN CHILDREN. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109309
Enrollment
36
Registered
2026-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F80- Specific developmental disorders of speech and language

Interventions

Intervention1: MINERAL SOURCES HOMOEOPATHIC MEDICINES: SELECTED HOMOEOPATHIC MEDICINE FROM MINERAL KINGDOM WILL BE GIVEN ON THE BASIS OF HOMOEOPATHIC POSOLOGY AND FOLLOW UP SHOULD BE DONE IN 28DAYS IN

Sponsors

RBTS GOVT HOMOEOPATHIC MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of both sexes. 2 Children aged 1 5 years. 3 Patients belonging to all socio-economic classes. 4 Children clinically diagnosed with speech and language delay, confirmed by: SLAS (Speech Language Assessment Scale) score below age appropriate cut-off. 5 Patients presenting with a symptom totality matching the similimum or nearest similimum from mineral-source homoeopathic medicines, with repertorisation employed as and when indicated. 6 Parents/guardians agree to allow required speech-language assessments and follow-up visits. 7 Parents/guardians willing to give written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1 Children below 1 year or above 5 years of age. 2 Children with normal SLAS score (i.e., not below age-appropriate cut-off). 3 Children with hearing impairment, uncorrected vision problems, or structural anomalies of the speech apparatus (cleft palate, tongue-tie). 4 Children with diagnosed autism spectrum disorder (ASD), Global Developmental Delay, Intellectual Disability, or major genetic syndromes affecting language. 5 Children with neurological disorders (uncontrolled epilepsy, cerebral palsy with severe motor impairment, neurodegenerative conditions). 6 Children with chronic diseases that interfere with participation in the study. 7 Children who have received individualized homoeopathic treatment for speech/language delay within the last 3 months. 8 Parents/guardians unwilling to provide consent or unable to ensure regular follow-up.

Design outcomes

Primary

MeasureTime frame
AT THE END OF THE STUDY, WE EXPECT POSITIVE RESPONSE OF HOMOEOPATHIC MEDICINE FROM MINERAL KINGDOM IN CASES OF SPEECH AND LANGUAGE DELAY IN CHILDRENTimepoint: 6 MONTHS TO 7 MONTHS

Secondary

MeasureTime frame
AT THE END OF THE STUDY OVERALL IMPROVEMENT OF THE PATIENT IS EXPECTED AND THE STUDY WILL ENCOURAGE THE PATEINT TO TAKE HOMOEOPATHIC MEDICINE IN CASES OF SPEECH AND LANGUAGE DELAYTimepoint: 6 MONTHS TO 7 MONTHS

Countries

India

Contacts

Public ContactDR PROF KUMAR RAVINDRA SINGH

RBTS GOVT MEDICAL COLLEGE AND HOSPITAL

drkrravindra1970@gmail.com9334112830

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026